Elicio Therapeutics, Inc

ELTXNASDAQ · Pharmaceutical Preparations

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

21.9M

on 2026-06-30, from 10.2M on 2024-03-31 10-Q ↗

a raise that quarter, at its price

Newest

$400.0M

S-3 of 2026-02-27. 1 prospectus supplement filed under it since. S-3 ↗

$100.0M

B. Riley Securities, agreement of 2026-03-16. No at-the-market sales statement read from a 10-Q or 10-K. 8-K ↗

Warrants

6.19M

Warrants of every class as tagged in the XBRL facts on 2026-06-30. 10-Q ↗

Cash

2.5 quarters

$23.5M on 2026-06-30 ÷ $9.4M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
Date	What	Shares	Price	Gross	Filing
2026-07-01	Registered direct offering	4,380,313	not read	$15.0M	8-K ↗
2026-07-01	Public offering	4,380,313	$3.43	$15.0M	424B5 ↗
2025-01-29	Public offering	1,261,830	$7.925	$10.0M	424B5 ↗
2025-01-29	Registered direct offering	1,261,830	not read	$10.0M	8-K ↗